Leerink Partners analyst David Risinger reiterated a Buy rating on Vaxcyte (PCVX – Research Report) on November 5 and set a price target ...

This quarterly report represents an earnings surprise of 66. ... What's Next for Target Hospitality? While Target Hospitality has underperformed the market so far this year, the question that comes to ...

Shortly after acquiring DS Smith, International Paper announced the closure of six U.S. facilities to streamline combined ...

Piper Sandler analyst Harsh Kumar raised the firm’s price target on Nvidia (NVDA) to $175 from $140 and keeps an Overweight rating on the ...

SKYX Platforms ranks at the bottom for Revenue Growth and Gross Profit, indicating lower performance in these areas compared ...

Arista Networks has additional value creation options via M&A and/or increased share buybacks. Learn why ANET stock is a Buy.

We recently compiled a list of the 13 AI News You Probably Missed. In this article, we are going to take a look at where ...

Nvidia Corporation's strong growth is driven by high-margin products and data center demand, but supply chain risks loom.

While a path toward the 270 Electoral College votes needed to take the White House remained in reach for both U.S.

We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...

Analysts expect Sangamo Therapeutics to report an earnings per share ... relative performance expectations and market positioning. Regenxbio received a Buy consensus from analysts, with an average ...

The Federal Reserve cut interest rates by a quarter point, the second reduction this year. A combination of strong data and ...